• Penumbra secured CE Mark in Europe for THUNDERBOLT, its computer-assisted vacuum thrombectomy system for acute ischemic stroke.
• The clearance supports a European rollout of the CAVT platform; the company also received U.S. FDA clearance last week.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Penumbra Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: SF83057) on June 15, 2026, and is solely responsible for the information contained therein.